Quetiapine in Patients with Borderline Personality Disorder: An Open-Label Trial

By Romine Ann  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 20, Iss. 4, 2008-11 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

The Efficacy and Tolerability of Duloxetine in the Treatment of Anxious Versus Non-Anxious Depression: A Post-Hoc Analysis of an Open-Label Outpatient Study

By Fava Maurizio   Martinez James M.   Greist John   Marangell Lauren B.   Brown Eileen   Chen Lei   Wohlreich Madelaine M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 19, Iss. 3, 2007-07 ,pp. : 187-195

Informa Healthcare

Access to resources Recommend Favorite

An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder

By Peuskens J.   Devoitille J. M.   Kusters J.   Vandenhoven G.  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 4, 2008-01 ,pp. : 261-267

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

By Menza M.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 153-158

Springer Publishing Company

Access to resources Recommend Favorite

Open-Label Dosage and Tolerability Study of Tiagabine Monotherapy in Patients with Refractory Complex Partial Seizures

By Schachter S.C.   Cahill W.T.   Wannamaker B.B.   Shu V.S.   Sommerville K.W.  

Journal of Epilepsy, Vol. 11, Iss. 5, 1998-09 ,pp. : 248-255

Elsevier

Access to resources Recommend Favorite